For many women over 50, navigating hormone therapy has meant choosing between options that weren't originally designed with their stage of life in mind. Pills, patches, and treatments developed primarily for younger women or contraceptive purposes have long been the standard, leaving a gap in care that one women's health physician is working to address.
Dr. Sarah Daccarett, founder of Inner Balance, recently launched Menopause Oestra, a bioidentical hormone therapy formulated specifically for menopausal women. The product is designed as a conservative starting dose of systemic hormone therapy, delivered vaginally to allow for more consistent absorption while reducing strain on the liver compared to oral options.
